Echinacoside ameliorates post-stroke depression by activating BDNF signaling through modulation of Nrf2 acetylation

Phytomedicine. 2024 Jun:128:155433. doi: 10.1016/j.phymed.2024.155433. Epub 2024 Feb 7.

Abstract

Background: Post-stroke depression (PSD) affects approximately one-third of stroke survivors, leading to adverse outcomes in rehabilitation, reduced quality of life, and increased mortality rates. Despite these implications, the underlying causes of PSD remain unclear, posing challenges for prevention and treatment. Echinacoside (ECH), a natural compound with known neuroprotective and antidepressant properties, holds significant therapeutic potential for PSD. However, the precise mechanism of its action remains unknown.

Purpose: To unravel the specific mechanism through which ECH alleviates PSD by exploring the intricate interplay between ECH and Nrf2, as well as its impact on the BDNF/TrkB signaling axis.

Study design and methods: A rat PSD model was established though middle cerebral artery occlusion coupled with chronic unpredictable mild stress, followed by ECH treatment. The rats' depressive state was evaluated using the sucrose preference test and force swimming test. Brain damage was assessed through TTC staining, Nissl staining, and TUNEL assay. The multifaceted mechanism of ECH in PSD was investigated using immunofluorescence, immunohistochemistry, RT-qPCR, dual-luciferase assay, and western blotting. Additionally, the interaction between ECH and Nrf2 was explored through molecular docking and microscale thermophoresis.

Results: Our findings unveiled a novel facet of ECH action, demonstrating its unique ability to upregulate Nrf2 through acetylation within the hippocampus of PSD-affected rats (p < 0.05). Moreover, ECH showcased its distinctive potential by enhancing BDNF transcriptional activity, activating the BDNF/TrkB signaling axis, and orchestrating a comprehensive response against oxidative stress and apoptosis, thereby alleviating PSD symptoms in rats (p < 0.05).

Conclusions: This study not only provides insights into the pivotal role of Nrf2 in mediating the BDNF/TrkB axis activation by ECH but also highlights the novelty of ECH's mechanism in addressing PSD. The elucidation of these unique aspects positions ECH as a groundbreaking candidate for further exploration and development in the realm of PSD intervention.

Keywords: Antidepressant effect; BDNF/TrkB signal axis; Echinacoside; Nrf2; Post-stroke depression.

MeSH terms

  • Acetylation
  • Animals
  • Antidepressive Agents / pharmacology
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Depression* / drug therapy
  • Depression* / etiology
  • Disease Models, Animal
  • Glycosides* / pharmacology
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Infarction, Middle Cerebral Artery / drug therapy
  • Male
  • Molecular Docking Simulation
  • NF-E2-Related Factor 2* / metabolism
  • Neuroprotective Agents / pharmacology
  • Rats
  • Rats, Sprague-Dawley*
  • Signal Transduction* / drug effects
  • Stroke* / complications
  • Stroke* / drug therapy

Substances

  • NF-E2-Related Factor 2
  • Brain-Derived Neurotrophic Factor
  • Nfe2l2 protein, rat
  • Bdnf protein, rat
  • echinacoside
  • Glycosides
  • Neuroprotective Agents
  • Antidepressive Agents